Lisa Ferri

1 week ago | mayerbrown.com | Lisa Ferri

OverviewThe UK Competition and Markets Authority (“CMA”) has recently published a decision accepting commitments from Vifor Pharma (“Vifor”). This brings to a close an unprecedented abuse of dominance investigation based on claims of disparagement, from which companies active on innovative markets, especially in the pharma sector, can draw valuable lessons.